Research Article

Overview of drugs used for the treatment of hypertension for elderly patients in Sanglah General Hospital, Denpasar, Bali

Archana Laxmi Pathmanathan , I Nyoman Gede Wardana, I Gusti Ayu Widianti

Archana Laxmi Pathmanathan
Medical Science Study Program, Medical Faculty, Universitas Udayana. Email:

I Nyoman Gede Wardana
Department of Anatomy, Medical Faculty, Universitas Udayana

I Gusti Ayu Widianti
Department of Anatomy, Medical Faculty, Universitas Udayana
Online First: June 17, 2019 | Cite this Article
Pathmanathan, A., Wardana, I., Widianti, I. 2019. Overview of drugs used for the treatment of hypertension for elderly patients in Sanglah General Hospital, Denpasar, Bali. Intisari Sains Medis 10(2). DOI:10.15562/ism.v10i2.215

Background: Hypertension is one of the most common diseases among elderly patients and it is also known as a silent killer. It could be due to excessive stress which causes the blood pressure to rise. The symptoms could appear, and people could go on for years without having any awareness of their disease.

Aim: This research was conducted to determine the prevalence of hypertension cases of elderly patients and the drugs used as a treatment for hypertension in Sanglah Hospital, Denpasar, Bali. The research was carried on in the Sanglah Hospital, Denpasar, Bali as of January until June 2017.

Method: In this study, a descriptive cross sectional study method was being used.

Result: As the age increases, the number of individuals with hypertension increases. In gender, we could see that the female has a higher prevalence compared to male. In Sanglah, we found that the mostly given drugs are amlodipine and captopril for elderly people as this drug works effectively for the patients. Other drugs such as valsartan, furosemide, and bisoprolol are also offered to patients with hypertension depending on their associated diseases.


Crim, M., Yoon, S., Ortiz, E., Wall, H., Schober, S., Gillespie, C., Sorlie, P., Keenan, N., Labarthe, D. and Hong, Y. National Surveillance Definitions for Hypertension Prevalence and Control Among Adults. Circulation: Cardiovascular Quality and Outcomes. 2012; 5(3): 343-51.

Lionakis, N., Mendrinos, D., Sanidas, E., Favatas, G. and Georgopoulou, M. Hypertension in the elderly. World Journal of Cardiology. 2012; 4(5): 135-147.

Flack, J., Sica, D. and Nesbitt, S. Chlorthalidone Versus Hydrochlorothiazide as the Preferred Diuretic: Is There a Verdict Yet?. Hypertension. 2011; 57(4): 665-666.

Weber, M., L. Schiffrin, E., B. White, W., Mann, S., H. Lindholm, L., G. Kenerson, J., M. Flack, J. and L. Carter, B. Clinical Practice Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension. The Journal of Clinical Hypertension. 2014; 16(1): 14 - 26.

Schäfer, H., Kaiser, E., and Lotze, U. Increasing complexity: which drug class to choose for treatment of hypertension in the elderly?. Clinical Interventions in Aging; 2014: 459.

Dasgupta, K., Quinn, R., Zarnke, K. and M. Rabi, D. The 2014 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. 2014; 30: 485 - 501.

McDonald, M., Hertz, R., Unger, A. and Lustik, M. PCV21 Prevalence Awareness and Management of Hypertension, Dyslipidemia, and Diabetes amongUnited Stated Adults Aged 65 and Older. The value in Health. 2008; 11(3): A192.

No Supplementary Material available for this article.
Article Views      : 203
PDF Downloads : 76